Cite
HARVARD Citation
McCarthy, N. et al. (2018). Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A2 formation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Atherosclerosis. pp. 42-49. [Online].